- 单位:南通大学 药理系
- 职称:教授
- 职位:系副主任
- 出生:1980.12
- 性别:女
- 社会职务: 江苏省药理学会教学专业委员会委员
- 微博:
研究领域
心血管药理学
论文与著作
[1] Man Wu R,Wang CY, Wang J, Xu XL(许晓乐). Promotingreverse cholesterol transport contributes to the amelioration ofatherosclerosis by paeoniflorin. Eur J Pharmacol. 2023 Dec15;961:176137.
[2] Wang J, WuR, Hua Y, Ling S, Xu X(许晓乐). Naringeninameliorates vascular senescence and atherosclerosis involving SIRT1 activation.JPharm Pharmacol. 2023 Aug 1;75(8):1021-1033.
[3] Wang CY,Wang J, Cao J, Xu J, Wu RM, Xu XL (许晓乐). ActivatingPGC-1alpha-mediated signaling cascades in the aorta contributes to theamelioration of vascular senescence and atherosclerosis by2,3,4',5-tetrahydroxystilbene-2-O-beta-d-glycoside. Phytomedicine. 2022May;99:154017.
[4] Zeng Y, Cao J, Li CX, Wang CY, Wu RM, Xu XL (许晓乐). MDM2-Mediated Ubiquitination of RXRbeta Contributes to MitochondrialDamage and Related Inflammation in Atherosclerosis. Int J Mol Sci. 2022 May21;23(10):5766.
[5] Hua YQ, Zeng Y, Xu J, Xu XL (许晓乐). Naringeninalleviates nonalcoholic steatohepatitis in middle-aged Apoe(-/-)mice: role ofSIRT1. Phytomedicine. 2021 Jan;81:153412.
[6] Zeng Y, Yan Wang C, Xu J, Le XuX (许晓乐). Overexpressionof retinoid X receptor beta provides protection against oxidized low-densitylipoprotein-induced inflammation via regulating PGC1alpha-dependentmitochondrial homeostasis in endothelial cells. Biochem Pharmacol. 2021Jun;188:114559.
[7] Zeng Y, Hua YQ, Wang W, Zhang H,Xu XL (许晓乐). Modulation of SIRT1-mediated signaling cascades in the liver contributesto the amelioration of nonalcoholic steatohepatitis in high fat fed middle-agedLDL receptor knockout mice by dihydromyricetin. Biochem Pharmacol. 2020May;175:113927.
[8] Zeng Y, Xu J, Hua YQ, Peng Y, XuXL(许晓乐). MDM2 contributes to oxidized low-density lipoprotein-induced inflammationthrough modulation of mitochondrial damage in endothelial cells. Atherosclerosis.2020 Jul;305:1-9.
[9] Xu J, Peng Y, Zeng Y, Hua YQ, XuXL (许晓乐). 2, 3, 4', 5-tetrahydroxystilbene-2-0-beta-d Glycoside Attenuates Age- andDiet-Associated Non-Alcoholic Steatohepatitis and Atherosclerosis in LDLReceptor Knockout Mice and Its Possible Mechanisms. Int J Mol Sci. 2019 Apr1;20(7):1617.
[10] Peng Y, Xu J, Zeng Y, Chen L, XuXL (许晓乐). Polydatin attenuates atherosclerosis in apolipoprotein E-deficient mice:Role of reverse cholesterol transport. Phytomedicine. 2019 Sep;62:152935.
[11] Tang K, Wang F, Zeng Y, Chen X, XuX (许晓乐). Salusin-alphaattenuates hepatic steatosis and atherosclerosis in high fat diet-fed lowdensity lipoprotein receptor deficient mice. Eur J Pharmacol. 2018 Jul5;830:76-86.
[12] Zeng Y, Peng Y, Tang K, Wang YQ, Zhao ZY, Wei XY, Xu XL (许晓乐). Dihydromyricetin ameliorates foam cell formation viaLXRα-ABCA1/ABCG1-dependent cholesterol efflux in macrophages. BiomedPharmacother. 2018 May:101:543-552.
[13] Chen X, Tang K, Peng Y, Xu X(许晓乐). 2,3,4',5-tetrahydroxystilbene
-2-O-beta-d-glycoside attenuates atherosclerosis in apolipoproteinE-deficient mice: role of reverse cholesterol transport. Can J Physiol Pharmacol.2018 Jan;96(1):8-17.
[14]Liu TT, Zeng Y, Tang K, Chen X, Zhang W, Xu XL (许晓乐). Dihydromyricetin ameliorates atherosclerosisin LDL receptor deficient mice. Atherosclerosis. 2017 Jul;262:39-50.
荣誉与奖励
作为药理系系副主任,领导药理系各项工作有序开展,更深入地开展了药理教研教改工作,改革并优化了课堂教学过程,提高了课堂教学效率和效果,在南通大学2014-2016年度优秀系(室)评选中本人所带领的药理系获特色系室奖。本人以第一作者发表教学文章3篇;以副主编身份参编《pharmacology》全英文教材一书(江苏大学出版社,ISBN 978-7-5684-0163-0);参编《药理学应试实训题解》一书(苏州大学出版社,ISBN 978-7-5672-0782-0);本人获2014年度南通大学优秀教学质量奖;获2015年度“南通大学优秀教育工作者”荣誉称号;获2015年南通大学研究生就业工作先进个人;获2016年度“南通大学第二批团青活力导师”称号;2016年作为唯一导师指导本科生获得获得国家级创新工程项目一项(No. 201610304040Z)。